Application Nr Approved Date Route Status External Links
NDA022128 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Selzentry Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Only Ccr5-Tropic Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Patients 2 Years Of Age And Older Weighing At Least 10 Kg. Limitations Of Use: • Selzentry Is Not Recommended In Patients With Dual/mixed- Or Cxcr4-Tropic Hiv-1 [See Microbiology ( 12.4 )]. Selzentry Is A Ccr5 Co-Receptor Antagonist Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Only Ccr5-Tropic Hiv-1 Infection In Patients 2 Years Of Age And Older Weighing At Least 10 Kg. ( 1 ) Limitations Of Use: • Not Recommended In Patients With Dual/mixed- Or Cxcr4 Tropic Hiv-1. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Maraviroc MARAVIROC ZINC100003902

Comments